Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 8, 2021 - Azurity Pharmaceuticals announced the FDA approval of Eprontia (topiramate).
Download PDF
Return to publications
